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Summary
Introduction:  Only  10%  of  intramuscular  hemangiomas  (IMH)  are  located  in  the  head  and  neck
region. There  are  very  few  reports  of  masseteric  location.  The  present  study  of  a  case  of
intra-masseteric  cavernous  hemangioma  discusses  clinical  presentation,  paraclinical  diagnostic
workup and  treatment  options.
Case  report:  A  70-year-old  male  patient  consulted  for  a  swelling  of  2  years’  evolution,  anterior
to the  left  parotid  gland.  The  swelling  was  ﬁrm,  painless,  well-contoured,  oblong,  3  cm  on  its
long axis,  and  located  in  the  masseter  muscle.  There  was  no  effect  of  head  position  on  tumor
volume.  MRI  showed  a  vascular  tumor.  Surgical  resection  was  performed  via  parotidectomy.
There were  no  postoperative  complications.  Pathological  examination  conﬁrmed  the  diagnosis
of cavernous  hemangioma.
Discussion:  Head  and  neck  IMH  is  commonly  located  in  the  masseter  muscle.  Evolution  is  slow.
Size is  variable,  contours  are  well  deﬁned  and  the  surface  is  smooth.  MRI  is  essential  ahead  of
treatment,  which  is  surgical  on  an  external  or  intra-oral  approach.
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Introduction
Hemangioma  is  a  vascular  tumor  of  unknown  etiology.  Intra-
muscular  hemangioma  (IMH)  constitutes  less  than  1%  of  cases
[1]  and  is  usually  located  in  the  skeletal  muscles  of  the
trunk  or  limbs  [1];  only  10%  are  located  in  head  and  neck
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egions  [2],  where  the  masseter  muscle  is  the  most  fre-
uent  location,  but  still  very  rare  [3].  Consultation  is  usually
rompted  by  a  mass  appearing  near  or  within  the  parotid
ossa.  Initial  diagnosis  is  usually  parotid  tumor,  hemangioma
eing  rarely  suspected  [4].  The  present  study  of  a case  of
ntra-masseteric  cavernous  hemangioma  presents  the  clin-
cal  aspect,  paraclinical  diagnostic  workup  and  treatment
ptions.ase report
 70-year-old  man  without  previous  history  consulted  2 years
fter  the  appearance  of  a  left  jugular  mass,  with  progressive
served.
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Figure  1  Preoperative  MRI.  A.  T1-weighted  axial  slice  without  injection.  The  tumor  is  well-contoured,  located  just  forward  of
the left  parotid  gland  (*);  it  shows  as  hypodense.  B.  T2-weighted  axial  slice.  The  mass  appears  hyperintense.  It  is  penetrated
by a  muscular  bundle  (arrow),  strongly  suggesting  development  within  the  masseter.  C.  T1-weighted  axial  Fat-Sat  sequence  with
gadolinium injection.  There  is  heterogeneous  uptake  within  the  tumor,  signifying  vascularity.
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mntermittent  pain  and  increased  mass  size  over  the  preceding
 months.  He  was  under  no  treatment.
The  swelling  was  located  in  contact  with  the  jugal  pro-
ongation  of  the  parotid  gland.  The  facing  skin  was  healthy,
ithout  signs  of  inﬂammation  or  collateral  venous  circula-
ion,  and  perfectly  mobile  with  respect  to  the  mass.  On
alpation,  the  mass  was  ﬁrm,  painless,  well  contoured,
blong,  3  cm  on  its  long  axis,  and  located  in  the  masseter
uscle.  Volume  was  unaffected  by  head  position.  MRI  found
 well-contoured  mass  within  the  masseter  muscle,  show-
ng  contrast-medium  uptake  (Fig.  1).  Vascular  tumor  was
iagnosed.  Surgery  was  performed  on  an  external  approach
ia  extra-facial  parotidectomy  with  resection  including  a
ew  masseter  ﬁbers  (Fig.  2).  Postoperative  course  was  free
f  complications,  with  no  facial  palsy.  Anatomopathology
onﬁrmed  the  diagnosis  of  cavernous  hemangioma  and  the
ompleteness  of  resection.  There  was  no  recurrence  over
4  months’  follow-up.
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igure  2  Surgery  via  left  parotidectomy.  A.  Approach  and  exposure
ioma exposed  after  opening  masseter  muscle.  B.  Resection.  1:  rese
asseter ﬁbers.iscussion
n  1957,  Scott  [5]  reported  a  series  of  393  IMHs,  12%  of  which
ere  head  and  neck  and  only  4.89%  in  the  masseter  muscle.
ince  then,  less  than  10  cases  of  IMH  have  been  reported
n  adults.  IMH  is  a  benign  congenital  tumor  without  genetic
eterminism.  In  90%  of  cases,  diagnosis  is  before  the  age  of
0  [3].  There  are  no  racial  factors.  Excessive  muscle  contrac-
ion  and  trauma  seem  to  be  important  etiological  factors;
ormonal  factors  also  play  a  role,  with  a  clear  increase  in
olume  correlated  to  menarche,  pregnancy  and  menstrual
ycle,  accounting  for  the  slight  female  predominance  found
or  IMH  in  general  [1],  although  there  is  a  male  predomi-
ance  for  masseteric  locations  [3].  In  almost  70%  of  cases,
ocation  is  in  a  single  muscle  [6]. IMH  presents  as  a  single
ass  of  variable  size,  mobile  and  relatively  ﬁrm.  More  than  a
alf  of  cases  have  associated  intermittent  pain,  due  to  mus-
le  compression.  Exceptionally,  the  skin  may  be  bluish,  with
.  1:  parotid  gland;  2:  mental  branch  of  facial  nerve;  3:  heman-
ction  cavity;  2:  hemangioma,  removed  with  some  surrounding
eter  
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local  heat  related  to  hypervascularization.  In  more  than  90%
of  cases,  however,  the  deep  location  and  surrounding  ﬁbro-
sis  belie  the  classical  clinical  description  of  hemangioma  as
a  blue,  soft,  compressible  tumor  [7].  Beating  and  thrill  are
exceptional  on  auscultation,  usually  being  masked  by  the
thickness  of  the  superﬁcial  muscular  layer.  Likewise,  it  is
very  unusual  to  for  tumor  size  to  be  increased  by  lowering
the  head—the  Wattle  sign,  which  would  be  highly  suggestive
[6].  Such  signs  are  found  in  masseteric  cases  only  when  the
tumor  is  superﬁcial  and  large.
Conventional  soft-tissue  radiology  may  ﬁnd  phleboliths,
to  be  distinguished  from  intraparotid  sialoliths  [2,7]. Echo-
Doppler  can  conﬁrm  the  vascular  nature  of  the  mass,  but
fails  to  determine  contours  and  relations  to  neighboring  tis-
sue  precisely,  as  can  be  done  with  contrast-enhancement  on
CT  and  especially  on  MRI:  these  examinations  have  become
references,  indispensable  ahead  of  treatment  [8]. Fine-
needle  aspiration  and  especially  biopsy  are  contraindicated,
being  dangerous  and  causing  severe  hemorrhage.  Arteriog-
raphy  is  indicated  only  for  large  tumors,  where  it  identiﬁes
the  arterial  pedicles  feeding  the  tumor  and  pre-operative
embolization,  thus  reducing  the  risk  of  peroperative  bleed-
ing  [9].
Several  non-surgical  treatments  have  been  described:
cryotherapy,  corticosteroid  or  sclerosant  injection,  isolated
embolization,  arterial  ligature  or  radiation  therapy;  results,
however,  have  been  controversial  [10],  and  such  methods
are  currently  recommended  only  where  surgery  is  con-
traindicated  or  refused  [9].
Complete  surgical  resection  is  the  curative  attitude.  Indi-
cations  are  sufﬁcient  tumor  size,  pain,  esthetic  blemish
and/or  functional  trouble  [1].  Preoperative  embolization
is  recommended  in  large  tumors.  Several  approaches  have
been  described.  Parotidectomy  is  the  most  common:  it  pro-
vides  good  exposure  but  requires  facial  nerve  dissection
and  partial  parotidectomy  [9].  An  intra-oral  route  is  pos-
sible,  with  mucosal  incision  anterior  to  Stenon’s  duct:  it
provides  a  direct  approach  with  good  lesion  visualization
and  local  control  of  bleeding  and  enables  direct  resection;
it  also  avoids  any  visible  scar  or  facial  nerve  dissection
[1].
[muscle  59
onclusion
ntramasseteric  hemangioma  is  a  rare  tumor,  often  mistak-
nly  assimilated  to  parotid  tumor.  Contrast-enhanced  CT  or
RI  is  essential  ahead  of  treatment.  Surgery  is  the  reference
ttitude;  various  surgical  approaches  are  possible.
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